Font Size: a A A

The Shenfu QXD Joint Xinmailong Injection Clinical Observation Of Treatment Of Heart Failure Disease (Heart Deficiency Syndrome)

Posted on:2014-10-30Degree:MasterType:Thesis
Country:ChinaCandidate:H ZhengFull Text:PDF
GTID:2254330425465668Subject:Integrative Medicine Internal Medicine
Abstract/Summary:PDF Full Text Request
Purpose:Further confirmed based on the ideology of the Chinese medicine syndrome differentiation joint blood circulation Yiqiwenyang Governance Act that:Shenfu QXD the the United Xinmailong injection and Western conventional therapy。Improve the clinical symptoms of heart failure disease (heart deficiency syndrome), the state and biochemical indicators of cardiac function better than the blood circulation conquer:Xinmailong injection combined with Western medicine conventional therapy. And observed adverse drug events.Method:Select from the Jiangsu Province Traditional Chinese Medicine Hospital, Cardiovascular Division, Department of Geriatrics,60cases of hospitalized cases were randomly divided into test group, the control group,30cases in each. Control group plus the senate in the Western conventional treatment to in Western conventional treatment plus Xinmailong injection therapy, test group QXD Xinmailong combination therapy. Clinical symptoms of to observe heart failure disease (heart deficiency syndrome), cardiac function and biochemical indicators to improve the situation. Results in statistical processing.Result:Test group BNP adjusted average number206.54±76.65, after the adjustment of the test group the number of287.65±98.63. The test group cTnI adjusted number of17.99±13.42, after adjustment of the test group the average number of24.80±10.21. Test group CRP adjusted mean7.98±5.61, the test group adjusted mean of13.03±7.54. After adjustment of the test group D-D2average number of0.26±0.12, after adjustment of the experimental group mean is0.35±0.13、Test group of diseases Points3.3±1.393, diseases integral of the control group,5.2±1.234.6、the test group symptom score4.500±1.383, control group symptoms integral6.400±1.278. These results were significant differences were statistically (p<0.05)Conclusion:Yiqiwenyang joint blood circulation Governing Law:the Shenfu United Xinmailong injection and Western conventional anti-heart failure treatment based QXD improve the clinical symptoms of heart failure disease (heart deficiency syndrome), heart function statuswith blood circulation and biochemical indicators of superior governance:Xinmailong injection combined with Western medicine conventional therapy. And the drugs of the control group and the treatment group, clinical application security.
Keywords/Search Tags:heart failure disease, heart deficiency syndrome, Shenfu QXD, Xinmailonginjection
PDF Full Text Request
Related items